Publications
- Phosphatidylserine-dependent anti-prothrombin antibodies (aPS/PT) in infliximab-treated patients with inflammatory bowel diseases2013 | First Faculty of Medicine
- Low serum deoxyribonuclease I activity is associated with antiTNF-alpha induced skin adverse events in patients with inflammatory bowel disease2012 | First Faculty of Medicine
- Influence of albuminemia on the pharmacokinetics of infliximab in patients with inflammatory bowel diseases2011 | First Faculty of Medicine
- Impaired Deoxyribonuclease I Activity in Patients with Inflammatory Bowel Diseases2011 | First Faculty of Medicine
- Serum infliximab trough levels and induction of antibodies to infliximab in patients with inflammatory bowel diseases2011 | First Faculty of Medicine
- Plasma calprotectin in chronically dialyzed end-stage renal disease patients2010 | First Faculty of Medicine
- Anti-inflammatory effect of biological treatment in patients with inflammatory bowel diseases: Calprotectin and IL-6 changes do not correspond to sRAGE changes2010 | First Faculty of Medicine
- Anticarbohydrate antibodies as markers of inflammatory bowel disease in a Central European cohort2010 | First Faculty of Medicine
- Calprotectin Levels in Patients with Inflammatory Bowel Disease - Comparison of Two Commercial Tests2008 | First Faculty of Medicine
- Clinical significance of anti-glycan antibodies in patients with Crohn's disease2008 | First Faculty of Medicine
Loading network view...